The initial sweat chloride concentrations, using the Orion sweat chloride meter, were borderline at around 55 mmol/l, but were reproducible within the variability of the method (±5 mmol/l at that time). Because of the strong clinical suspicion of cystic fibrosis, and because he was being treated with sodium cloxacillin, I performed several further tests in the following two weeks and observed a rise in sweat chloride to 120 mmol/l after withdrawal of the treatment. The subsequent progress of the disease in this child confirmed the diagnosis. The assays were all performed by myself, and I do not believe that I was observing spurious results as falsely low sweat chlorides are unusual artefacts with this method, and the technique we use is rigorously standardised to avoid this. There was also good agreement between duplicate readings at different sites on each occasion.
Since that occasion we have made a particular note of the treatment of tested children and have seen only one other similar case, in a child with cystic fibrosis who was on ampicillin at the time of first testing. We were unable to perform the repeat tests as often as in our first case, however, and I could not be so sure that technical problems did not affect this observation.
Thus 
